Comparative Study of Different Doses of Magnesium as a Protective Agent in Nephrotoxicity in Cancer Patients

Clinical trial NCT05586009 · COMPLETED

Trial details

NCT number: NCT05586009
Sponsor: Tanta University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cisplatin Adverse Reaction

Start date: 2022-10-01
Primary completion: 2025-02-27
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.